The antiserum was produced against synthesized peptide derived from human MEF2D around the phosphorylation site of Ser444. AA range:410-459

Phospho-MEF-2D (S444) Polyclonal Antibody detects endogenous levels of MEF-2D protein only when phosphorylated at S444.The name of modified sites may be influenced by many factors, such as species (the modified site was not originally found in human samples) and the change of protein sequence (the previous protein sequence is incomplete, and the protein sequence may be prolonged with the development of protein sequencing technology). When naming, we will use the "numbers" in historical reference to keep the sites consistent with the reports. The antibody binds to the following modification sequence (lowercase letters are modification sites):PVsPS

MEF2D

Myocyte-specific enhancer factor 2D

MEF2D ;
Myocyte-specific enhancer factor 2D

This gene is a member of the myocyte-specific enhancer factor 2 (MEF2) family of transcription factors. Members of this family are involved in control of muscle and neuronal cell differentiation and development , and are regulated by class II histone deacetylases. Fusions of the encoded protein with Deleted in Azoospermia-Associated Protein 1 (DAZAP1) due to a translocation have been found in an acute lymphoblastic leukemia cell line , suggesting a role in leukemogenesis. The encoded protein may also be involved in Parkinson disease and myotonic dystrophy. Alternative splicing results in multiple transcript variants. [provided by RefSeq , Oct 2012] ,

developmental stage:Present in myotubes and also in undifferentiated myoblasts. ,Domain:The beta domain , missing in a number of isoforms , is required for enhancement of transcriptional activity. ,Function:Transcriptional activator which binds specifically to the MEF2 element , 5'-YTA[AT] (4) TAR-3' , found in numerous muscle-specific , growth factor- and stress-induced genes. Mediates cellular functions not only in skeletal and cardiac muscle development , but also in neuronal differentiation and survival. Plays diverse roles in the control of cell growth , survival and apoptosis via p38 MAPK signaling in muscle-specific and/or growth factor-related transcription. Plays a critical role in the regulation of neuronal apoptosis. ,PTM:Acetylated on Lys-439 by CREBBP. Deacetylated by SIRT1. ,PTM:Phosphorylated on Ser-444 by CDK5 is required for Lys-439 sumoylation and inhibits transcriptional activity. In neurons , enhanced CDK5 activity induced by neurotoxins promotes caspase 3-mediated cleavage leading to neuron apoptosis. Phsophorylation on Ser-180 can be enhanced by EGF. ,PTM:Proteolytically cleaved in cerebellar granule neurons on several sites by caspase 7 following neurotoxicity. Preferentially cleaves the CDK5-mediated hyperphosphorylated form which leads to neuron apoptosis and transcriptional inactivation. ,PTM:Sumoylated on Lys-439 by SUMO2 but not SUMO1; which inhibits transcriptional activity and myogenic activity. Desumoylated by SENP3. ,similarity:Belongs to the MEF2 family. ,similarity:Contains 1 MADS-box domain. ,similarity:Contains 1 Mef2-type DNA-binding domain. ,subcellular location:Translocated by HDAC4 to nuclear dots. ,subunit:Forms a complex with class II HDACs in undifferentiating cells. On myogenic differentiation , HDACs are released into the cytoplasm allowing MEF2s to interact with other proteins for activation. Interacts with HDAC4 (in undifferentiating cells) ; the interaction translocates MEF2D to nuclear dots. Forms a heterodimer with MEF2A. ,

Nucleus . Translocated by HDAC4 to nuclear dots.

>>cGMP-PKG signaling pathway ;
>>Apelin signaling pathway ;
>>Parathyroid hormone synthesis , secretion and action